ar4023 1478-6354 Letter <p>Response to 'Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice'</p> KimGn2080707@hyumc.com KimThink-Youtykim@hanyang.ac.kr

Department of Early Arthritis/Laboratory of Medicine, The Hospital for Rheumatic Diseases, Hanyang University Medical Center, 133-792 Seoul, Republic of Korea

 Arthritis Research & Therapy 1478-6354 2012 14 5 404 http://arthritis-research.com/content/14/5/404 See related research by Hsieh et al., http://arthritis-research.com/content/13/5/R162 2297991810.1186/ar4023 1092012 2012BioMed Central Ltd

We read with interest the recent paper by Hsieh and colleagues 1 asserting that cytomegalovirus (CMV) induces systemic lupus erythematosus (SLE) in genetically susceptible individuals. This assertion is based on the idea that SLE-associated autoantibodies that had been induced by a certain fragment of CMV were found in rodents. However, our previous studies have reported that autoantibodies detected in SLE and viral infection are different, especially with regard to the anti-microtubule organizing center with microtubule (anti-MTOC-MT) 234. We conducted a retrospective study comparing autoantibodies in three groups: anti-CMV IgM-positive SLE patients (SLE-CMV group); anti-CMV IgM-positive patients without SLE (CMV group); and anti-CMV IgM-negative SLE patients (SLE group). This study was approved by the institutional review board of Hanyang University Medical Center.

Autoantibodies from 245 patients were analyzed from January 2005 to March 2012 by the autoimmune target (AIT) test, which was developed to overcome the limitations of the antinuclear antibody test using the human macrophage cell line (IT-1) as a substrate 2.

What is noteworthy is that anti-MOTC-MT was highly detected in the CMV group, while it was not detected in all SLE patients regardless of CMV infection. Moreover, if CMV is a cause of SLE, detected autoantibodies between the SLE-CMV and CMV groups should overlap, but they show a clear distinction (Table 1).

<p>Table 1</p>

Immunofluorescence patterns and titers of AIT test in SLE-CMV, SLE and CMV groups

Titer

Patterns from AIT test

≤1:20

1:40

1:80

1:160

1:320

1:640

1:1280

≥1:2560

Total

SLE-CMV groupa

Homogeneous

2

9

11

Homogeneous + speckled

4

13

17

Homogeneous + cytoplasmic

1

1

Homogeneous + diffuse granular

4

4

Homogeneous + speckled + cytoplasmic

3

3

Speckled

1

8

9

Speckled + cytoplasmic

1

1

2

Diffuse granular + cytoplasmic

1

1

Diffuse cytoplasmic + speckled

3

3

Diffuse cytoplasmic + diffuse granular

2

2

Total

0

0

0

1

0

6

1

45

53

SLE groupb

Homogeneous

1

2

15

18

Homogeneous + speckled

2

3

33

38

Homogeneous + cytoplasmic

2

2

Homogeneous + diffuse granular

1

12

13

Homogeneous + speckled + cytoplasmic

2

1

4

7

Speckled

5

3

5

34

47

Speckled + cytoplasmic

1

3

3

3

10

Diffuse granular + cytoplasmic

2

1

5

8

Diffuse granular

1

5

7

13

Diffuse cytoplasmic + speckled

9

9

Diffuse cytoplasmic + diffuse granular

1

1

2

Diffuse cytoplasmic + nucleolar

1

2

3

Total

0

0

0

0

12

10

22

126

170

CMV groupc

MTOC-MT

4

4

1

1

1

11

MTOC-MT + IF + speckled

1

1

2

1

5

Speckled

2

2

Negative

4

4

Total

4

1

7

6

1

1

2

0

22

aSLE-CMV group, anti-CMV IgM-positive SLE patients; bSLE group, anti-CMV IgM-negative SLE patients; cCMV group, anti-CMV IgM-positive patients without SLE. The AIT test was performed using an indirect immunofluorescent test kit (IT-AIT™; ImmunoThink Co., Seoul, Republic of Korea). In the CMV group, anti-MTOC-MT-positive patients accounted for 72.7% of the total patients in the CMV group and 88.9% of autoantibody-positive patients, but in the SLE-CMV group, anti-MTOC-MT was not detected at all (P < 0.001). Patients in the SLE-CMV group showed high titers of over 1:640 except for one who received steroid pulse therapy just before the test, but the proportion of patients in the CMV group with a titer over 1:640 was not more than 13.6% (P < 0.001). In addition, most of the autoantibody frequently found in the SLE-CMV group was not found in the CMV group. AIT, autoimmune target; CMV, cytomegalovirus; IF, intermediate filament; MTOC-MT, microtubule organizing center with microtubule; SLE, systemic lupus erythematosus.

CMV becomes latent in multiple organs and can later be reactivated during severe dysregulation of the immune system. In our study, over 90% of patients in the three groups were anti-CMV IgG-positive. Detection of anti-CMV IgG implies the presence of latent virus, but anti-CMV IgG does not protect the individual from reactivation of the latent virus. In contrast, anti-CMV IgM responses are often seen during reactivation of CMV, so it seems that CMV infection in the SLE-CMV group was not caused by primary infection but by reactivation of CMV. MTOC, cytokines and T cells are closely coordinated to maintain the immune system 5 and anti-MTOC-MT is not found in SLE patients owing to impairment of the immune system. In conclusion, we postulate that CMV is not sufficiently intense to cause SLE, but is reactivated in some SLE patients as an innocent bystander.

Abbreviations

AIT: autoimmune target; CMV: cytomegalovirus; MTOC-MT: microtubule organizing center with microtubule; SLE: systemic lupus erythematosus.

Competing interests

Think-You Kim holds patents relating to the IT-1 cell line.

 <p>Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice</p>HsiehAHJhouYJLiangCTChangMWangSLArthritis Res Ther201113R16210.1186/ar3481330809521989080<p>Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus</p>JearnLHKimDAKimTYJ Rheumatol2009361833183419671822<p>MTOC-MT is a major target antigen of autoantibody detected by autoimmune target tests in patients with hepatitis A virus infection</p>SirJUKimTYJ Clin Pathol201063112920924090<p>Autoantibodies are commonly detected by the AIT test in patients with chronic hepatitis C virus infection</p>SirJUKimTYJ Viral Hepat20101737910.1111/j.1365-2893.2009.01202.x19780942<p>MTOC translocation modulates IS formation and controls sustained T cell signaling</p>Martín-CófrecesNBRobles-ValeroJCabreroJRMittelbrunnMGordón-AlonsoMSungCHAlarcónBVázquezJSánchez-MadridFJ Cell Biol20081829516210.1083/jcb.200801014252857418779373